EUVIMEDEUVIMED entdecken
Crossref

Iron metabolism biomarkers and mortality risk in U.S. patients with congestive heart failure: NHANES 1999–2018 analysis

Chunyan Li, Fushu Zhou, Jing Wu, Dongliang Fu, Xianlun Li, Wenquan Niu

Nutrition, Metabolism and Cardiovascular Diseases · 2024

DOI: 10.1016/j.numecd.2024.05.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2024. Verfasst von Chunyan Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Integrated Traditional Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing, China. Electronic address: l…. Hauptthemen laut MEDLINE: Heart Failure, Biomarkers, Iron, Nutrition Surveys. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Iron deficiency is a major public health concern. We aimed to assess the predictive capability of 4 iron metabolism biomarkers for all-cause and cardiovascular disease-specific mortality in U.S. patients with congestive heart failure (CHF). METHODS AND RESULTS: 1904 CHF patients aged ≥20 years were enrolled from NHANES, 1999-2000 to 2017-2018. All analyses were weighted to provide nationally representative estimates. Among 1905 CHF patients, mean age was 71 years, and 1024 (53.8%), 459 (24.1%), 206 (10.8%), and 216 (11.3%) were Non-Hispanic Black, Non-Hispanic White, Hispanic-Mexican American, and Hispanic-Other Hispanic, respectively. During follow-ups, 1080 deaths occurred. Median follow-up time was 5.08 years. Per-unit increase in natural-logarithmic-transformed iron and transferrin saturation decreased all-cause mortality risk separately by 33.0% (adjusted hazard ratio: 0.670, 95% confidence interval: 0.563 to 0.797, P < 0.001) and 32.6% (0.674, 0.495 to 0.917, 0.013), and per-unit increase in transferrin receptor increased mortality risk by 33.7% (1.337, 1.104 to 1.618, 0.004). Two derivates from 3 significant iron biomarkers were generated - transferrin receptor to natural-logarithmic-transformed iron ratio (TRI) and transferrin receptor to natural-logarithmic-transformed transferrin saturation ratio (TRTS), which were significantly associated with all-cause mortality, with per-unit increase corresponding to 2.692- and 1.655-fold increased all-cause mortality risk (P: 0.003 and 0.023). Only iron and TRTS were associated with the significant risk of cardiovascular disease-specific mortality (P: 0.004 and 0.017). CONCLUSIONS: Our findings identified 3 iron metabolism biomarkers that were individually, significantly, and independently associated with all-cause mortality in patients with CHF, and importantly 2 derivates generated exhibited stronger predictive capability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureBiomarkersIronNutrition SurveysCause of DeathTransferrinHumansMaleFemaleAgedMiddle AgedRisk AssessmentUnited StatesRisk FactorsTime FactorsPrognosisAged, 80 and overPredictive Value of TestsAnemia, Iron-Deficiency

Stichwörter der Autor:innen

All-cause mortalityCardiovascular disease-specific mortalityCongestive heart failureIron metabolism biomarkerSurvival

Substanzen

BiomarkersIronTransferrin

Autor:innen und Institutionen

  • Department of Cardiology, Integrated Traditional Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing, China. Electronic address: lcyzryhyy@sina.com.
  • Department of Cardiology, Shahe Hospital, Beijing, China.
  • Center for Evidence-Based Medicine, Capital Institute of Pediatrics, Beijing, China.
  • Department of Cardiology, Integrated Traditional Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing, China.
  • Department of Cardiology, Integrated Traditional Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing, China. Electronic address: leexianlun@163.com.
  • Center for Evidence-Based Medicine, Capital Institute of Pediatrics, Beijing, China. Electronic address: niuwenquan_shcn@163.com.

Zitieren

APA

Li, C., Zhou, F., Wu, J., Fu, D., Li, X., & Niu, W. (2024). Iron metabolism biomarkers and mortality risk in U.S. patients with congestive heart failure: NHANES 1999–2018 analysis. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2024.05.027

Vancouver

Li C, Zhou F, Wu J, Fu D, Li X, Niu W. Iron metabolism biomarkers and mortality risk in U.S. patients with congestive heart failure: NHANES 1999–2018 analysis. Nutrition, Metabolism and Cardiovascular Diseases. 2024. doi:10.1016/j.numecd.2024.05.027

BibTeX
@article{Li2024,
  author = {Li, Chunyan and Zhou, Fushu and Wu, Jing and Fu, Dongliang and Li, Xianlun and Niu, Wenquan},
  title = {Iron metabolism biomarkers and mortality risk in U.S. patients with congestive heart failure: NHANES 1999–2018 analysis},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2024},
  doi = {10.1016/j.numecd.2024.05.027}
}
Kostenlos starten →